Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Quarterly Sales
Pharma
Legend sloughs off Carvykti threat from J&J's Tecvayli
Executives from Legend Biotech showed little concern for a potential threat to its lone commercial product, multiple myeloma CAR-T Carvykti.
Kevin Dunleavy
Mar 12, 2026 2:00pm
Lilly shines in Q4 as peers brace for 2026 slowdown
Mar 11, 2026 3:00pm
BioNTech shares drop after leaders' departure announcement
Mar 10, 2026 11:28am
Galderma doubles Nemluvio peak sales outlook to $4B-plus
Mar 5, 2026 11:20am
Bayer's pharma division sees one more year of declining sales
Mar 4, 2026 11:35am
Argenx's Vyvgart posts ph. 3 win in ocular myasthenia gravis
Feb 26, 2026 11:18am
